berberine has been researched along with Malaria in 6 studies
Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.
Excerpt | Relevance | Reference |
---|---|---|
" In this study, a new semi-synthetic berberine analogue, 5,6-didehydro-8,8-diethyl-13-oxodihydroberberine chloride (1), showed nanomolar level potency against in vitro models of leishmaniasis, malaria, and trypanosomiasis as well as activity in an in vivo visceral leishmaniasis model." | 3.77 | Potent antiprotozoal activity of a novel semi-synthetic berberine derivative. ( Anklin, C; Bahar, M; Deng, Y; Doskotch, RW; Drew, ME; Gil, RR; He, S; Kinghorn, AD; Navarro-Vázquez, A; Pandharkar, T; Werbovetz, KA; Zhu, X, 2011) |
"Berberine is an isoquinoline alkaloid isolated from Chinese herbs such as Coptidis Rhizome." | 2.47 | Advances in structural modifications and biological activities of berberine: an active compound in traditional Chinese medicine. ( Chen, WM; Huang, ZJ; Lan, P; Sun, PH; Zeng, Y, 2011) |
"KRas is frequently mutated in pancreatic cancers." | 1.62 | GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals. ( Abrams, SL; Akula, SM; Candido, S; Cervello, M; Cocco, L; Duda, P; Falzone, L; Gizak, A; Libra, M; Martelli, AM; McCubrey, JA; Meher, AK; Montalto, G; Rakus, D; Ratti, S; Ruvolo, P; Steelman, LS, 2021) |
" The orally bioavailable lead imidazolopiperazine confers complete causal prophylactic protection (15 milligrams/kilogram) in rodent models of malaria and shows potent in vivo blood-stage therapeutic activity." | 1.37 | Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. ( Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Meister, S | 1 |
Plouffe, DM | 1 |
Kuhen, KL | 1 |
Bonamy, GM | 1 |
Wu, T | 1 |
Barnes, SW | 1 |
Bopp, SE | 1 |
Borboa, R | 1 |
Bright, AT | 1 |
Che, J | 1 |
Cohen, S | 1 |
Dharia, NV | 1 |
Gagaring, K | 1 |
Gettayacamin, M | 1 |
Gordon, P | 1 |
Groessl, T | 1 |
Kato, N | 1 |
Lee, MC | 1 |
McNamara, CW | 1 |
Fidock, DA | 1 |
Nagle, A | 1 |
Nam, TG | 1 |
Richmond, W | 1 |
Roland, J | 1 |
Rottmann, M | 1 |
Zhou, B | 1 |
Froissard, P | 1 |
Glynne, RJ | 1 |
Mazier, D | 1 |
Sattabongkot, J | 1 |
Schultz, PG | 1 |
Tuntland, T | 1 |
Walker, JR | 1 |
Zhou, Y | 1 |
Chatterjee, A | 1 |
Diagana, TT | 1 |
Winzeler, EA | 1 |
Abrams, SL | 1 |
Akula, SM | 1 |
Meher, AK | 1 |
Steelman, LS | 1 |
Gizak, A | 1 |
Duda, P | 1 |
Rakus, D | 1 |
Martelli, AM | 1 |
Ratti, S | 1 |
Cocco, L | 1 |
Montalto, G | 1 |
Cervello, M | 1 |
Ruvolo, P | 1 |
Libra, M | 1 |
Falzone, L | 1 |
Candido, S | 1 |
McCubrey, JA | 1 |
Kume, A | 1 |
Herbas, MS | 1 |
Shichiri, M | 1 |
Ishida, N | 1 |
Suzuki, H | 1 |
Bahar, M | 1 |
Deng, Y | 1 |
Zhu, X | 1 |
He, S | 1 |
Pandharkar, T | 1 |
Drew, ME | 1 |
Navarro-Vázquez, A | 1 |
Anklin, C | 1 |
Gil, RR | 1 |
Doskotch, RW | 1 |
Werbovetz, KA | 1 |
Kinghorn, AD | 1 |
Huang, ZJ | 1 |
Zeng, Y | 1 |
Lan, P | 1 |
Sun, PH | 1 |
Chen, WM | 1 |
Talwalkar, SS | 1 |
Vaidya, AB | 1 |
Godse, C | 1 |
Vaidya, A | 1 |
Vaidya, R | 1 |
1 review available for berberine and Malaria
Article | Year |
---|---|
Advances in structural modifications and biological activities of berberine: an active compound in traditional Chinese medicine.
Topics: Alzheimer Disease; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antimalarials; Antineop | 2011 |
5 other studies available for berberine and Malaria
Article | Year |
---|---|
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Topics: Animals; Antimalarials; Cell Line, Tumor; Drug Discovery; Drug Evaluation, Preclinical; Drug Resista | 2011 |
GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals.
Topics: Adenocarcinoma; Adenylate Kinase; Antineoplastic Agents; bcl-X Protein; Berberine; Biphenyl Compound | 2021 |
Effect of anti-hyperlipidemia drugs on the alpha-tocopherol concentration and their potential for murine malaria infection.
Topics: alpha-Tocopherol; Animals; Anticholesteremic Agents; Antimalarials; Berberine; Cholestyramine Resin; | 2016 |
Potent antiprotozoal activity of a novel semi-synthetic berberine derivative.
Topics: Animals; Antiprotozoal Agents; Berberine; Chlorocebus aethiops; Disease Models, Animal; Inhibitory C | 2011 |
Plasmodium DNA fluoresces with berberine: a novel approach for diagnosis of malarial parasites.
Topics: Animals; Berberine; DNA, Protozoan; Fluorescence; Humans; Malaria; Plasmodium; Staining and Labeling | 2005 |